Mental Health Clinical Trials: Depression, Anxiety, and PTSD
Published April 6, 2026 · ClinicalTrials.gov data
Mental health research is undergoing a renaissance. After decades of incremental progress, the field is seeing genuinely new approaches: psychedelic-assisted therapy, rapid-acting antidepressants, digital therapeutics, and neurostimulation technologies. For the one in five American adults living with a mental health condition, clinical trials offer access to treatments that may work where conventional options have not.
Important: This is not medical advice. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988. Talk to your doctor about whether a clinical trial is right for you.
Psychedelic Research: A New Frontier
The most talked-about development in psychiatric research is the clinical testing of psychedelic compounds in controlled therapeutic settings:
- Psilocybin for depression: Multiple Phase 2 and 3 trials are testing psilocybin-assisted therapy for treatment-resistant depression and major depressive disorder. Early results show rapid, sustained improvements in some patients after just one or two sessions.
- MDMA for PTSD: MDMA-assisted therapy showed strong results in Phase 3 trials for PTSD. While the FDA advisory committee raised manufacturing and study design concerns, the therapeutic approach continues to be refined in new trials.
- Ketamine derivatives: Building on the success of esketamine (Spravato), researchers are testing new formulations and delivery methods for rapid-acting antidepressant effects.
Treatment-Resistant Depression
Roughly one-third of people with depression don't respond adequately to standard antidepressants. This has made treatment-resistant depression (TRD) one of the most active trial categories:
- Novel drug mechanisms: Drugs targeting the glutamate system, neuroinflammation, and opioid receptors (without addiction risk) are in trials
- Neurostimulation: New TMS protocols (like Stanford Neuromodulation Therapy) and deep brain stimulation are being tested for severe, refractory depression
- Combination approaches: Pairing psychotherapy with pharmacology in structured protocols, including psychedelic-assisted therapy
Digital Therapeutics and AI
A growing number of trials are testing technology-based mental health interventions:
- Prescription digital therapeutics (PDTs), FDA-regulated software that delivers CBT, mindfulness, or behavioral activation
- AI-powered chatbots for between-session support and symptom monitoring
- Virtual reality exposure therapy for PTSD and phobias
- Wearable sensors that detect mood changes and trigger early interventions
Recruiting Mental Health Trials
What to Expect in a Mental Health Trial
Mental health trials often differ from other medical trials:
- Therapy component: Many trials combine medication with structured psychotherapy sessions
- Rating scales: You'll complete standardized questionnaires (like the PHQ-9 for depression or PCL-5 for PTSD) at regular intervals
- Washout periods: Some trials require you to taper off current medications before starting, this must be done under medical supervision
- Placebo considerations: Placebo-controlled mental health trials are carefully designed with safety monitoring and rescue medication protocols
Frequently Asked Questions
Are psychedelic clinical trials available for depression?
Yes. Psilocybin (the active compound in psychedelic mushrooms) is in Phase 2 and 3 clinical trials for treatment-resistant depression and major depressive disorder. MDMA-assisted therapy has been studied for PTSD. These trials are conducted in controlled clinical settings with trained therapists. Talk to your doctor about whether a clinical trial is right for you.
Can I join a clinical trial for treatment-resistant depression?
Yes, and trials specifically for treatment-resistant depression (TRD) are one of the most active areas of psychiatric research. Options include psilocybin therapy, ketamine/esketamine variations, TMS (transcranial magnetic stimulation) protocols, and novel drug mechanisms. Most TRD trials require that you've tried at least two antidepressants without adequate response. Talk to your doctor about whether a clinical trial is right for you.
What mental health conditions have the most clinical trials?
Depression has the most trials, followed by schizophrenia, anxiety disorders, PTSD, and substance use disorders. There are currently 1565 mental health-related trials recruiting participants.
Are digital therapy clinical trials legitimate?
Yes. The FDA has cleared several digital therapeutics (prescription software apps) for substance use disorders and insomnia, and more are in clinical trials. These studies test whether app-based cognitive behavioral therapy, biofeedback, or AI-guided interventions can improve outcomes, either alone or combined with medication. Talk to your doctor about whether a clinical trial is right for you.
About This Data
Trial data from ClinicalTrials.gov API v2, last updated June 26, 2026. Recruiting counts reflect actively enrolling studies. This is not medical advice, talk to your doctor about clinical trials. See our methodology.
Related
More clinical-trial guides in your inbox
Get more clinical-trial guides by email. No spam, unsubscribe anytime.